Delivery Order SPE2DB22D1106-SPE2DB25FFAN9
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Cervidil 10 mg vaginal inserts, a pharmaceutical product used in obstetric care. This firm fixed-price delivery order, valued at $3,384.40, was competitively awarded without set-aside designation and carries an ultimate completion date of July 30, 2025. The contract was awarded on July 29, 2025, with performance to be completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,384.40 to AmerisourceBergen Drug Corp for the supply of Cervidil 10 mg vaginal inserts. This is a firm fixed-price, competitive award with no set-aside designation, issued on August 4, 2025, with an ultimate completion date of August 5, 2025. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $2,030.64 for Cervidil 10 mg vaginal inserts by the Defense Logistics Agency's Medical Supply Chain. The contract was competitively awarded without set-aside provisions and carries a firm fixed price structure with an ultimate completion date of August 5, 2025. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Cervidil 10 mg vaginal inserts, with a ceiling value of $5,415.04 under a firm fixed-price contract type. The contract carries an ultimate completion date of July 21, 2025, and represents a non-set-aside, competitively awarded delivery order. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,030.64 to AmerisourceBergen Drug Corp for the supply of Cervidil 10 mg vaginal inserts. This firm fixed-price contract, awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a non-competitive delivery order under DLA's existing pharmaceutical supply framework. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- This federal contract award is for the delivery of Cervidil 10 mg vaginal inserts, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,149.80 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,115.97 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of CERVIDIL 10 MG VAGINAL INSRTS. This delivery order is part of a larger indefinite delivery contract (IDC) between Amerisourcebergen Drug Corp and DLA, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen Drug Corp to...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,707.52, is for the delivery of CERVIDIL 10 MG vaginal inserts. It is a firm fixed-price delivery order contract with a completion date of March 10, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Cervidil 10 mg vaginal inserts. The ceiling value of the delivery order is $1,211.20, with a completion date of May 16, 2023. This award is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a...
- This federal contract award is for the delivery of CERVIDIL 10 MG VAGINAL INSRTS to the Defense Logistics Agency (DLA), a defense agency. The $3,047.06 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 5, 2024 with a completion date of September 6, 2024. The contract is not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFAN9Delivery Order
The Defense Logistics Agency awarded a $3,384.40 delivery order to AmerisourceBergen Drug Corp for Cervidil 10 mg vaginal inserts, with an ultimate completion date of July 31, 2025. This is a competitively awarded, firm fixed price contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications, vaccines, syringes, and medical test kits across multiple therapeutic domains. The company has demonstrated capability to meet federal procurement requirements through its consistent receipt of competitively awarded delivery orders from the Defense Logistics Agency's Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 7/30/25 |